EUVIMEDSkopri EUVIMED
BeobachtungsstudieOpen access · CC BY-NC 3.0

Serum Metabolomics Analysis Revealed Metabolic Pathways Related to AECOPD Complicated with Anxiety and Depression

Jing Ye, Ping Li iD, Pengcheng Liu, Wenjing Pei iD, Ruowen Wang, Hui Liu, Changxiu Ma, Dahai Zhao

International Journal of Chronic Obstructive Pulmonary Disease · 2024-09 · Volume 19 · 2135-2151

DOI: 10.2147/copd.s471817 ↗

At a glance

Beobachtungsstudie in International Journal of Chronic Obstructive Pulmonary Disease, 2024-09. Written by Jing Ye and 7 co-authors. Institution: Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601, People's Repu…. Major MEDLINE topics: Metabolomics, Pulmonary Disease, Chronic Obstructive, Depression, Anxiety. Cited 4 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC 3.0). Funded by: Clinical Research and Cultivation Plan Project of the Second Affiliated Hospital of Anhui Medical University, Translational Medicine Research Fund Project of the Second Affiliated Hospital of Anhui Medical University, natural science research projects in colleges and universities in Anhui Province.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Anxiety and depression are two of the most common comorbidities of COPD, which can directly lead to the number of acute exacerbations and hospitalizations of COPD patients and reduce their quality of life. At present, there are many studies on anxiety and depression in stable COPD, but few studies on anxiety and depression in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients.

Objective

We aim to explore the changes of serum metabolomics in AECOPD complicated with anxiety and depression and to provide some clues for further understanding its pathogenesis.

Methods

This is an observational high-throughput experimental study based on retrospective data extraction. Twenty-one AECOPD with anxiety and depressive patients and 17 healthy controls (HCs) were retrospectively enrolled in the Second Affiliated Hospital of Anhui Medical University. Hamilton anxiety scale (HAMA) and Hamilton depression scale (HAMD) for anxiety and depression were used to assess the patients with AECOPD. Untargeted metabolomics analysis was carried out to investigate different molecules in the serum of all participants. General information of all participants, baseline data and clinical measurement data of AECOPD patients were collected. Statistical analysis and bioinformatics analysis were performed to reveal different metabolites and perturbed metabolic pathways.

Results

A total of 724 metabolites in positive ionization mode and 555 metabolites in negative ionization mode were different in AECOPD patients with anxiety and depression. The 1,279 serum metabolites could be divided into 77 categories. Based on multivariate and univariate analysis, 74 metabolites were detected in positive ionization mode, and 60 metabolites were detected in negative ionization as differential metabolites. The 134 metabolites were enriched in 18 pathways, including biosynthesis of unsaturated fatty acids, aldosterone synthesis and secretion, protein digestion and absorption, ovarian steroidogenesis, long-term depression, retrograde endocannabinoid signaling, and so on.

Conclusion

This work highlights the key metabolites and metabolic pathways disturbed in AECOPD patients with anxiety and depression. These findings support the use of metabolomics to understand the pathogenic mechanisms involved in AECOPD patients with anxiety and depression.

Subjects

MeSH terms (MEDLINE)

MetabolomicsPulmonary Disease, Chronic ObstructiveDepressionAnxietyBiomarkersHumansFemaleMaleAgedMiddle AgedRetrospective StudiesMetabolic Networks and PathwaysChinaDisease ProgressionMetabolome

Author keywords

AECOPDanxietydepressionexacerbationmetabolomics

Substances

Biomarkers

Authors and institutions

  • Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601, People's Republic of China.
  • Institute of Respiratory Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601, People's Republic of China.

ORCID profiles: Ping Li, Wenjing Pei

Funding

  • Clinical Research and Cultivation Plan Project of the Second Affiliated Hospital of Anhui Medical University
  • Translational Medicine Research Fund Project of the Second Affiliated Hospital of Anhui Medical University
  • natural science research projects in colleges and universities in Anhui Province

Cite

APA

Ye, J., Li, P., Liu, P., Pei, W., Wang, R., Liu, H., Ma, C., & Zhao, D. (2024). Serum Metabolomics Analysis Revealed Metabolic Pathways Related to AECOPD Complicated with Anxiety and Depression. International Journal of Chronic Obstructive Pulmonary Disease, Volume 19, 2135-2151. https://doi.org/10.2147/copd.s471817

Vancouver

Ye J, Li P, Liu P, Pei W, Wang R, Liu H, et al. Serum Metabolomics Analysis Revealed Metabolic Pathways Related to AECOPD Complicated with Anxiety and Depression. International Journal of Chronic Obstructive Pulmonary Disease. 2024;Volume 19:2135-2151. doi:10.2147/copd.s471817

BibTeX
@article{Ye2024,
  author = {Ye, Jing and Li, Ping and Liu, Pengcheng and Pei, Wenjing and Wang, Ruowen and Liu, Hui and Ma, Changxiu and Zhao, Dahai},
  title = {Serum Metabolomics Analysis Revealed Metabolic Pathways Related to AECOPD Complicated with Anxiety and Depression},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2024},
  volume = {Volume 19},
  pages = {2135--2151},
  doi = {10.2147/copd.s471817}
}
Start for free →